Skip to main content

Animations

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2493${count})

  • Rapid Response Innovation Awards, 2009
    Development of Potent Conformation-Specific Compounds Directed to Monomeric Alpha-Synuclein

    Promising Outcomes of Original Grant:
    The goal of our original funded grant was to use our alpha-synuclein assay to identify compounds that prevent conformational change to the fully open form of the...

  • Improving Delivery of Parkinson's Disease Therapeutics to th, 2010
    Novel Antibodies for the Delivery of Parkinson's Therapeutics

    Promising Outcomes of Original Grant:
    The initial granting period resulted in the successful identification of antibodies capable of targeting and internalizing into novel in vitro blood-brain barrier...

  • Rapid Response Innovation Awards, 2009
    Evaluation of a Viral Non-coding RNA as a Neuroprotective and Neurorestorative Therapy in Chronic Models of Parkinson's Disease

    Promising Outcomes of Original Grant:
    Previously, we asked whether a novel viral non-coding RNA (an RNA which does not appear to encode a protein), but with known pro-life functions, could act to...

  • Target Validation, 2010
    Validation of VPS41, a Protein Involved in Lysosomal Trafficking, as a Target for Parkinson Disease Therapy

    Promising Outcomes of Original Grant:
    VPS41 was identified in a C. elegans system. In the original funded grant, we demonstrated that human VPS41 (hVPS41) was also protective in C. elegans, performed a...

  • MJFF Research Grant, 2009
    N-Acetylcysteine CSF Levels and Biomarkers in a Pre-clinical Model of PD

    Objective/Rationale:
    N-Acetylcysteine (NAC) is an orally absorbed compound that supports neuronal synthesis of glutathione, a key neuronal antioxidant.  Our objective here is to establish the blood and...

  • MJFF Research Grant, 2010
    Promoting Widespread Data Sharing Among Scientists

    Objective/Rationale
    When scientists carry out experiments and observations, they typically have very specific questions.  It is frequently the case that data collection is relevant to issues and...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.